RE:RE:RE:RE:RE:"impressive, paradigm shifting, photodynamic therapy"Lets keep in mind AA criteria have changed recently. Now most all applicants must show that they have confirmatory trial in place, and in some instances even patinet enrollment. My mind keeps coming back to these new 9 sites. What is their purpose? Perhaps this senario: BTD for 25 patients at 450 in coming weeks/months; AA by end of year after submission of additional 450 data, (say an additional 20-25 patients); then use 9 additional sites to help complete total enrollment by end of 2023. Our completion of the trial with 450 day serveliance can then serve as our confirmatory obligation to satisfy full FDA approval late 2024 or early 2025.